Jiayu Zhu

Jiayu Zhu

Auto-generated profile, based on publicly available information

Jiayu Zhu

Department of Medicine, The University of Chicago, IL, USA

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2016 in Free Radical Biology and Medicine
Verified
Journal Article
Closed access
JZJiayu Zhu
Jiayu Zhu
HWHuihui Wang
Huihui Wang
FCFeng Chen
Feng Chen
Jingqi FuJingqi Fu
Jingqi Fu
Yuanyuan XuYuanyuan Xu
Yuanyuan Xu
Jingbo PiJingbo Pi
Jingbo Pi

1 November 2018 in Toxicology and Applied Pharmacology
Verified
Journal Article
Closed access
JZJiayu Zhu
Jiayu Zhu
HWHuihui Wang
Huihui Wang
FCFeng Chen
Feng Chen
HLHang Lv
Hang Lv
ZXZijin Xu
Zijin Xu
Jingbo PiJingbo Pi
Jingbo Pi

21 January 2022 in Science Advances
Verified
Journal Article
Open access
CYChih-Fan Yeh
Chih-Fan Yeh
SCShih-Hsin Cheng
Shih-Hsin Cheng
YLYu-Shan Lin
Yu-Shan Lin
TSTzu-Pin Shentu
Tzu-Pin Shentu
RHRu-Ting Huang
Ru-Ting Huang
KYKai-Chien Yang
Kai-Chien Yang
Although atherosclerosis preferentially develops at arterial curvatures and bifurcations where disturbed flow (DF) activates endothelium, therapies targeting flow-dependent mechanosensing pathways in the vasculature are unavailable. Here, we provided experimental evidence demonstrating a previously unidentified causal role of DF-induced endothelial TXNDC5 (thioredoxin domain containing 5) in atherosclerosis. TXNDC5 was increased in human and mouse atherosclerotic lesions and induced in endothelium subjected to DF. Endothelium-specific Txndc5 deletion markedly reduced atherosclerosis in ApoE −/− mice. Mechanistically, DF-induced TXNDC5 increases proteasome-mediated degradation of heat shock factor 1, leading to reduced heat shock protein 90 and accelerated eNOS (endothelial nitric oxide synthase) protein degradation. Moreover, nanoparticles formulated to deliver Txndc5 -targeting CRISPR-Cas9 plasmids driven by an endothelium-specific promoter ( CDH5 ) significantly increase eNOS protein and reduce atherosclerosis in ApoE −/− mice. These results delineate a new molecular paradigm that DF-induced endothelial TXNDC5 promotes atherosclerosis and establish a proof of concept of targeting endothelial mechanosensitive pathways in vivo against atherosclerosis.

1 March 2018 in Free Radical Biology and Medicine
Verified
Journal Article
Closed access
HWHuihui Wang
Huihui Wang
JZJiayu Zhu
Jiayu Zhu
ZLZhiyuan Liu.
Zhiyuan Liu.
HLHang Lv
Hang Lv
PLPeng Lv
Peng Lv
Jingbo PiJingbo Pi
Jingbo Pi

17 January 2024 in Journal of Cell Biology
Verified
Journal Article
Open access
PDF file
JLJin Li
Jin Li
JZJiayu Zhu
Jiayu Zhu
OGOlivia Gray
Olivia Gray
DSDébora R. Sobreira
Débora R. Sobreira
DWDavid Wu
David Wu
YFYun Fang
Yun Fang
Vascular homeostasis and pathophysiology are tightly regulated by mechanical forces generated by hemodynamics. Vascular disorders such as atherosclerotic diseases largely occur at curvatures and bifurcations where disturbed blood flow activates endothelial cells while unidirectional flow at the straight part of vessels promotes endothelial health. Integrated analysis of the endothelial transcriptome, the 3D epigenome, and human genetics systematically identified the SNP-enriched cistrome in vascular endothelium subjected to well-defined atherosclerosis-prone disturbed flow or atherosclerosis-protective unidirectional flow. Our results characterized the endothelial typical- and super-enhancers and underscored the critical regulatory role of flow-sensitive endothelial super-enhancers. CRISPR interference and activation validated the function of a previously unrecognized unidirectional flow-induced super-enhancer that upregulates antioxidant genes NQO1, CYB5B, and WWP2, and a disturbed flow-induced super-enhancer in endothelium which drives prothrombotic genes EDN1 and HIVEP in vascular endothelium. Our results employing multiomics identify the cis-regulatory architecture of the flow-sensitive endothelial epigenome related to atherosclerosis and highlight the regulatory role of super-enhancers in mechanotransduction mechanisms.

1 December 2017 in Toxicology and Applied Pharmacology
Verified
Journal Article
Closed access
HWHuihui Wang
Huihui Wang
JZJiayu Zhu
Jiayu Zhu
LLLu Li
Lu Li
YLYongfang Li
Yongfang Li
HLHang Lv
Hang Lv
Jingbo PiJingbo Pi
Jingbo Pi